Clinical trial
GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer
NCT00400517
Study timeline
Study start (unknown)2003-03-01Date precision: month
Registry last updated2018-08-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
sargramostimBIOLOGICAL
thalidomideDRUG · verified · RxNorm: thalidomide
conventional surgeryPROCEDURE
neoadjuvant therapyPROCEDURE
Sponsors & collaborators
The Cleveland Cliniclead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00400517 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.